Gene · 2213
Papers4,232
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,232
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy. | Front Immunol | 2022 | 36685519 | PubTator, text mining | PubMed |
| Proteomic Characterization of PAMs with PRRSV-ADE Infection. | Viruses | 2022 | 36680075 | PubTator, text mining | PubMed |
| Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis. | Biomolecules | 2022 | 36671474 | PubTator, text mining | PubMed |
| Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations. | Expert Rev Neurother | 2022 | 36645654 | PubTator, text mining | PubMed |
| Neutrophil dynamics and inflammaging in acute ischemic stroke: A transcriptomic review. | Front Aging Neurosci | 2022 | 36620775 | PubTator, text mining | PubMed |
| Tumour microenvironment landscape and immunotherapy response in bladder cancer decoded by stromal MOXD1 based on copper-related genes signature. | Front Oncol | 2022 | 36620542 | PubTator, text mining | PubMed |
| Lineage Reconstruction of In Vitro Identified Antigen-Specific Autoreactive B Cells from Adaptive Immune Receptor Repertoires. | Int J Mol Sci | 2022 | 36613668 | PubTator, text mining | PubMed |
| The Anti-Inflammatory and Immunomodulatory Activities of Natural Products to Control Autoimmune Inflammation. | Int J Mol Sci | 2022 | 36613560 | PubTator, text mining | PubMed |
| The Role of Bromodomain and Extraterminal (BET) Proteins in Controlling the Phagocytic Activity of Microglia In Vitro: Relevance to Alzheimer's Disease. | Int J Mol Sci | 2022 | 36613460 | PubTator, text mining | PubMed |
| Systemic Therapy for HER2-Positive Metastatic Breast Cancer: Current and Future Trends. | Cancers (Basel) | 2022 | 36612047 | PubTator, text mining | PubMed |
| A Review of Margetuximab-Based Therapies in Patients with HER2-Positive Metastatic Breast Cancer. | Cancers (Basel) | 2022 | 36612034 | PubTator, text mining | PubMed |
| The role of lymphoid tissue SPARC in the pathogenesis and response to treatment of multiple myeloma. | Front Oncol | 2022 | 36605435 | PubTator, text mining | PubMed |
| Focusing on NK cells and ADCC: A promising immunotherapy approach in targeted therapy for HER2-positive breast cancer. | Front Immunol | 2022 | 36601109 | PubTator, text mining | PubMed |
| Higher TYROBP and lower SOX6 as predictive biomarkers for poor prognosis of clear cell renal cell carcinoma: A pilot study. | Medicine (Baltimore) | 2022 | 36595751 | PubTator, text mining | PubMed |
| Editorial: Systemic lupus erythematosus - predisposition factors, pathogenesis, diagnosis, treatment and disease models. | Front Immunol | 2022 | 36591294 | PubTator, text mining | PubMed |
| Density dependent regulation of inflammatory responses in macrophages. | Front Immunol | 2022 | 36591218 | PubTator, text mining | PubMed |
| Clinicopathological characteristics and genetic alterations in clear cell carcinoma cells derived from Mullerian duct epithelium of the prostate. | Chin Med J (Engl) | 2022 | 36583865 | PubTator, text mining | PubMed |
| Basophils from allergy to cancer. | Front Immunol | 2022 | 36578500 | PubTator, text mining | PubMed |
| Fc receptor engagement of HIV-1 Env-specific antibodies in mothers and infants predicts reduced vertical transmission. | Front Immunol | 2022 | 36578481 | PubTator, text mining | PubMed |
| Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative. | Vaccines (Basel) | 2022 | 36560400 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2213/papers?page=33